Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
- 23 September 2008
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 372 (9651), 1746-1755
- https://doi.org/10.1016/s0140-6736(08)61309-4
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Immune intervention at diagnosis ? should we treat children to preserve beta-cell function?Pediatric Diabetes, 2007
- Insulin Treatment in Patients With Type 1 Diabetes Induces Upregulation of Regulatory T-Cell Markers in Peripheral Blood Mononuclear Cells Stimulated With Insulin In VitroDiabetes, 2006
- Current Issues in the Treatment of Human Diseases by Mucosal ToleranceAnnals of the New York Academy of Sciences, 2004
- Intranasally administered insulin intended for prevention of type 1 diabetes—a safety study in healthy adultsDiabetes/Metabolism Research and Reviews, 2003
- Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice.JCI Insight, 1997
- Oral Administration of the Immunodominant B-chain of Insulin Reduces Diabetes in a Co-transfer Model of Diabetes in the NOD Mouse and is Associated with a Switch from Th1 to Th2 CytokinesJournal of Autoimmunity, 1997
- HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group.JCI Insight, 1996
- Rapid HLA-DQB1 Genotyping for Four Alleles in the Assessment of Risk for IDDM in the Finnish PopulationDiabetes Care, 1996
- Active Suppression of Diabetes after Oral Administration of Insulin Is Determined by Antigen DosageAnnals of the New York Academy of Sciences, 1996
- Theory and Practice of Nicotinamide Trials in Pre-Type 1 DiabetesJournal of Pediatric Endocrinology and Metabolism, 1996